ForeverGreen Exceeding Company Expectations

In recent weeks, ForeverGreen Worldwide (OTCQB – FVRG - $1.66 – Spec Buy) has issued a series of press releases that indicate the Company is exceeding its original expectations for 2014.

Earlier this month, ForeverGreen announced that February 2014 revenue exceeded February 2013 performance by more than 300%. This news comes on the heels of an earlier release proclaiming that January 2014 revenue exceeded January 2013 revenue by more than 160%. Not only is the Company hitting on all cylinders but the rate of top-line growth is accelerating and it is possible that monthly revenue could approach the $3 million mark and first half revenue could approach the $16 - $18 million in revenue slated for the entire year in 2013.

We should note it is unreasonable to expect these levels to be sustained throughout the year. However, they provide insight into the outperformance of the first two months, relative to original management expectations of $35 - $40 million for this year. Moreover, the Company appears to be properly managing growth and the diversification of revenue going forward, as investors should expect the introduction of new products this year that should generate a few million in revenue alone. Plus, management has set the stage for an even stronger infrastructure in order to sustain high revenue growth rates. For example, continues to add distributors at record rates and by mid-year, ForeverGreen expects to double the current number of active distributors. Just as important as the addition of new distributors is the change in marketing structure. The Company recently modified the structure to seamlessly connect FGXpress and ForeverGreen to allow more cross selling capabilities among all of the company’s products and further strengthen distributor retention.

At current levels, the shares appear to be dirt cheap, considering the hockey stick-type revenue growth FVRG is experiencing. Moreover, the higher the growth rate at these levels, the more likely that profitability will be greater as well this year. It is possible that as the Company releases its 2013 and 1Q14 financial results, these shares will come under major accumulation. Since management’s plan is to up-list the shares to a senior exchange in the coming quarters, opportunistic investors can enjoy the potential of outsized gains based on fundamentals, valuation, and the commencement of the up-listing process.

For more information, refer to our previous sponsored FVRG Reports, Updates and Hot Topics by visiting www.GoldmanResearch.com

You Might Also Like

Our NASDAQ Pick of the Year Goes Ex-Dividend Friday - November 24, 2023
Web3 Pioneer Poised for Future Valuation Hikes Thursday - November 9, 2023
An Emerging Cancer and Autoimmune Player Wednesday - October 4, 2023
Under-the-Radar AI-Driven Biotech to Surge Higher Thursday - August 24, 2023
TRNR: High Growth, Low Valuation Stock Offers Major Upside Thursday - August 17, 2023

Senior Analyst: Robert Goldman

Rob Goldman founded Goldman Small Cap Research in 2009 and has over 20 years of investment and company research experience as a senior research analyst and as a portfolio and mutual fund manager. During his tenure as a sell side analyst, Rob was a senior member of Piper Jaffray's Technology and Communications teams. Prior to joining Piper, Rob led Josephthal & Co.'s Washington-based Emerging Growth Research Group. In addition to his sell-side experience Rob served as Chief Investment Officer of a boutique investment management firm and Blue and White Investment Management, where he managed Small Cap Growth portfolios and The Blue and White Fund.

Analyst Certification

I, Robert Goldman, hereby certify that the view expressed in this research report accurately reflect my personal views about the subject securities and issuers. I also certify that no part of my compensation was, is, or will be, directly or indirectly, related to the recommendations or views expressed in this research report.

Disclaimer

This Opportunity Research Microcap Hot Topics article was prepared for informational purposes only.

Goldman Small Cap Research, (a division of Two Triangle Consulting Group, LLC) produces research via two formats: Goldman Select Research and Goldman Opportunity Research. The Select format reflects the Firm’s internally generated stock ideas along with economic and stock market outlooks. Opportunity Research reports, updates and Microcap Hot Topics articles reflect sponsored (paid) research but can also include non-sponsored micro cap research ideas that typically carry greater risks than those stocks covered in the Select Research category. It is important to note that while we may track performance separately, we utilize many of the same coverage criteria in determining coverage of all stocks in both research formats. Research on stocks in the Opportunity Research format typically have a higher risk profile, and may offer greater upside. Since May 2013, Goldman Small Cap Research has been compensated $500 by a third party for this article.

Goldman Small Cap Research is not affiliated in any way with Goldman Sachs & Co.

This article is the opinion of Goldman Small Cap Research and was written based upon publicly available information. The Company has not endorsed or compensated Goldman Small Cap Research for this article. All information contained in this report was provided by the Company or derived from GSCR due diligence. Our analysts are responsible only to the public, and are paid in advance to eliminate pecuniary interests, retain editorial control, and ensure independence. Analysts are compensated on a per report basis and not on the basis of his/her recommendations.

The information used and statements of fact made have been obtained from sources considered reliable but we neither guarantee nor represent the completeness or accuracy. Goldman Small Cap Research did not make an independent investigation or inquiry as to the accuracy of any information provided by the Company, or other firms. Goldman Small Cap Research relied solely upon information provided by the Company through its filings, press releases, presentations, and through its own internal due diligence for accuracy and completeness. Such information and the opinions expressed are subject to change without notice. A Goldman Small Cap Research report, update, article, or note is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed.

This publication does not take into account the investment objectives, financial situation, or particular needs of any particular person. This report does not provide all information material to an investor’s decision about whether or not to make any investment. Any discussion of risks in this presentation is not a disclosure of all risks or a complete discussion of the risks mentioned. Neither Goldman Small Cap Research, nor its parent, is registered as a securities broker-dealer or an investment adviser with FINRA, the U.S. Securities and Exchange Commission or with any state securities regulatory authority.

ALL INFORMATION IN THIS REPORT IS PROVIDED “AS IS” WITHOUT WARRANTIES, EXPRESSED OR IMPLIED, OR REPRESENTATIONS OF ANY KIND. TO THE FULLEST EXTENT PERMISSIBLE UNDER APPLICABLE LAW, TWO TRIANGLE CONSULTING GROUP, LLC WILL NOT BE LIABLE FOR THE QUALITY, ACCURACY, COMPLETENESS, RELIABILITY OR TIMELINESS OF THIS INFORMATION, OR FOR ANY DIRECT, INDIRECT, CONSEQUENTIAL, INCIDENTAL, SPECIAL OR PUNITIVE DAMAGES THAT MAY ARISE OUT OF THE USE OF THIS INFORMATION BY YOU OR ANYONE ELSE (INCLUDING, BUT NOT LIMITED TO, LOST PROFITS, LOSS OF OPPORTUNITIES, TRADING LOSSES, AND DAMAGES THAT MAY RESULT FROM ANY INACCURACY OR INCOMPLETENESS OF THIS INFORMATION). TO THE FULLEST EXTENT PERMITTED BY LAW, TWO TRIANGLE CONSULTING GROUP, LLC WILL NOT BE LIABLE TO YOU OR ANYONE ELSE UNDER ANY TORT, CONTRACT, NEGLIGENCE, STRICT LIABILITY, PRODUCTS LIABILITY, OR OTHER THEORY WITH RESPECT TO THIS PRESENTATION OF INFORMATION.

For more information, visit our Disclaimer: www.goldmanresearch.com